Your browser doesn't support javascript.
loading
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
Hammerschmidt, Swantje I; Bosnjak, Berislav; Bernhardt, Günter; Friedrichsen, Michaela; Ravens, Inga; Dopfer-Jablonka, Alexandra; Hoffmann, Markus; Pöhlmann, Stefan; Behrens, Georg M N; Förster, Reinhold.
Afiliação
  • Hammerschmidt SI; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Bosnjak B; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Bernhardt G; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Friedrichsen M; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Ravens I; Institute of Immunology, Hannover Medical School, Hannover, Germany.
  • Dopfer-Jablonka A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Hoffmann M; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Pöhlmann S; Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
  • Behrens GMN; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
  • Förster R; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Cell Mol Immunol ; 18(10): 2455-2456, 2021 10.
Article em En | MEDLINE | ID: mdl-34426672
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Female / Humans / Male Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Female / Humans / Male Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha